Silverarc Capital Management, LLC Closed Holding Positions

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
Medicus Sciences Acquisition
Q2 2022 Filed on Jul 25, 2022
131,151
N/A
JNCE
Jounce Therapeutics, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
248,347
$2.8 - $7.67 $695K - $1.9M
GLPG
Galapagos Nv

Healthcare
Q2 2022 Filed on Jul 25, 2022
41,002
$52.3 - $71.59 $2.14M - $2.94M
ASLN
Aslan Pharmaceuticals LTD

Healthcare
Q2 2022 Filed on Jul 25, 2022
500,000
$0.36 - $0.9 $180K - $450K
LPTX
Leap Therapeutics, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
1,032,163
$0.96 - $1.91 $991K - $1.97M
NXTC
Next Cure, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
196,187
$3.38 - $5.27 $663K - $1.03M
SRRA
Sierra Oncology, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
443,381
$33.76 - $54.99 $15M - $24.4M
LHDX
Lucira Health, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
310,734
$1.44 - $3.94 $447K - $1.22M
APTX
Aptinyx Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
201,600
$0.38 - $2.58 $76.6K - $520K
CYCC
Cyclacel Pharmaceuticals, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
462,659
$6.1 - $7.15 $2.82M - $3.31M
BNTC
Benitec Biopharma Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
492,880
$0.74 - $2.29 $365K - $1.13M
ITOS
I Teos Therapeutics, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
138,843
$16.57 - $35.1 $2.3M - $4.87M
NBIX
Neurocrine Biosciences Inc

Healthcare
Q2 2022 Filed on Jul 25, 2022
20,482
$75.79 - $100.07 $1.55M - $2.05M
Calithera Biosciences Inc
Q2 2022 Filed on Jul 25, 2022
221,809
N/A
ATHA
Athira Pharma, Inc.

Healthcare
Q2 2022 Filed on Jul 25, 2022
10,000
$2.74 - $13.43 $27.4K - $134K
KURA
Kura Oncology, Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
66,812
$11.78 - $16.98 $787K - $1.13M
VTGN
Vista Gen Therapeutics, Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
424,181
$1.14 - $2.09 $484K - $887K
Social Cap Suvretta Hlds Crp
Q1 2022 Filed on May 13, 2022
123,862
N/A
DNAA
Social Capital Suvretta Holdings Corp. I
Q1 2022 Filed on May 13, 2022
123,862
$9.62 - $9.98 $1.19M - $1.24M
Research Alliance Corp Ii
Q1 2022 Filed on May 13, 2022
556,890
N/A
DNAD
Social Capital Suvretta Holdings Corp. Iv

Financial Services
Q1 2022 Filed on May 13, 2022
123,862
$9.61 - $9.89 $1.19M - $1.22M
DNAC
Social Capital Suvretta Holdings Corp. Iii
Q1 2022 Filed on May 13, 2022
123,862
$9.78 - $9.92 $1.21M - $1.23M
AUPH
Aurinia Pharmaceuticals Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
100,000
$10.05 - $22.48 $1.01M - $2.25M
IPHA
Innate Pharma Sa

Healthcare
Q1 2022 Filed on May 13, 2022
184,046
$2.7 - $4.8 $497K - $883K
CRIS
Curis Inc

Healthcare
Q1 2022 Filed on May 13, 2022
200,000
$2.31 - $5.13 $462K - $1.03M
INBX
Inhibrx, Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
24,666
$19.89 - $43.18 $491K - $1.07M
DCPH
Deciphera Pharmaceuticals, Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
160,526
$6.87 - $11.11 $1.1M - $1.78M
HALO
Halozyme Therapeutics, Inc.

Healthcare
Q1 2022 Filed on May 13, 2022
71,009
$31.97 - $41.06 $2.27M - $2.92M
CBIO
Catalyst Biosciences, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
10,000
$0.91 - $4.16 $9.1K - $41.6K
CABA
Cabaletta Bio, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
42,022
$3.36 - $14.64 $141K - $615K
ZNTL
Zentalis Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
23,855
$66.92 - $84.79 $1.6M - $2.02M
RAPT
Rapt Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
11,796
$29.5 - $39.5 $348K - $466K
ARCT
Arcturus Therapeutics Holdings Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
6,208
$34.2 - $47.56 $212K - $295K
EVLO
Evelo Biosciences, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
61,700
$6.07 - $12.0 $375K - $740K
SURF
Surface Oncology, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
50,000
$4.73 - $7.9 $237K - $395K
ADGI
Adagio Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
5,000
$6.35 - $47.04 $31.8K - $235K
Dicerna Pharmaceuticals Inc
Q4 2021 Filed on Feb 14, 2022
31,040
N/A
AFMD
Affimed N.V.

Healthcare
Q4 2021 Filed on Feb 14, 2022
47,182
$5.37 - $7.07 $253K - $334K
CYBN
Cybin Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
250,000
$1.13 - $2.31 $283K - $578K
GH
Guardant Health, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
4,218
$88.71 - $120.43 $374K - $508K
KROS
Keros Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
10,000
$36.95 - $62.89 $370K - $629K
Adamas Pharmaceuticals Inc
Q4 2021 Filed on Feb 14, 2022
288,042
N/A
AYLA
Ayala Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
40,956
$8.32 - $12.45 $341K - $510K
CCXI
Chemo Centryx, Inc.
Q4 2021 Filed on Feb 14, 2022
139,200
$18.38 - $40.5 $2.56M - $5.64M
Arena Pharmaceuticals Inc
Q4 2021 Filed on Feb 14, 2022
18,581
N/A
RNLX
Renalytix PLC

Healthcare
Q4 2021 Filed on Feb 14, 2022
37,000
$13.43 - $27.4 $497K - $1.01M
DCTH
Delcath Systems, Inc.

Healthcare
Q3 2021 Filed on Nov 15, 2021
99,189
$8.44 - $12.65 $837K - $1.25M
ETON
Eton Pharmaceuticals, Inc.

Healthcare
Q3 2021 Filed on Nov 15, 2021
18,691
$4.2 - $6.26 $78.5K - $117K
KDNY
Chinook Therapeutics, Inc.

Healthcare
Q3 2021 Filed on Nov 15, 2021
14,158
$11.5 - $14.86 $163K - $210K
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email